89bio Inc (ETNB)
8.00
+0.02
(+0.25%)
USD |
NASDAQ |
Nov 21, 11:01
89bio Price: 8.00 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 8.07 | 8.07 | 7.675 | 7.98 | 674060.0 |
| Nov 19, 2024 | 7.86 | 8.02 | 7.79 | 7.99 | 720278.0 |
| Nov 18, 2024 | 7.84 | 8.015 | 7.71 | 7.975 | 2.063M |
| Nov 15, 2024 | 8.85 | 8.85 | 7.85 | 7.93 | 1.434M |
| Nov 14, 2024 | 8.88 | 9.07 | 8.64 | 8.75 | 1.850M |
| Nov 13, 2024 | 9.10 | 10.01 | 8.91 | 8.915 | 2.899M |
| Nov 12, 2024 | 9.87 | 9.99 | 8.94 | 9.05 | 948317.0 |
| Nov 11, 2024 | 10.60 | 10.72 | 10.03 | 10.05 | 516030.0 |
| Nov 08, 2024 | 9.55 | 10.53 | 9.000 | 10.45 | 760377.0 |
| Nov 07, 2024 | 10.17 | 10.43 | 9.725 | 9.96 | 717950.0 |
| Nov 06, 2024 | 9.82 | 10.35 | 9.55 | 10.17 | 1.408M |
| Nov 05, 2024 | 9.25 | 9.49 | 8.98 | 9.23 | 828594.0 |
| Nov 04, 2024 | 8.90 | 9.52 | 8.87 | 9.29 | 1.183M |
| Nov 01, 2024 | 7.82 | 9.50 | 7.67 | 9.14 | 1.994M |
| Oct 31, 2024 | 8.01 | 8.140 | 7.77 | 7.78 | 478599.0 |
| Oct 30, 2024 | 8.10 | 8.25 | 7.97 | 7.99 | 405807.0 |
| Oct 29, 2024 | 8.02 | 8.19 | 7.955 | 8.18 | 319859.0 |
| Oct 28, 2024 | 8.02 | 8.38 | 7.87 | 8.02 | 358522.0 |
| Oct 25, 2024 | 7.79 | 8.10 | 7.75 | 7.87 | 293373.0 |
| Oct 24, 2024 | 7.81 | 7.99 | 7.69 | 7.77 | 290240.0 |
| Oct 23, 2024 | 8.10 | 8.16 | 7.750 | 7.81 | 686918.0 |
| Oct 22, 2024 | 8.11 | 8.19 | 8.01 | 8.12 | 293029.0 |
| Oct 21, 2024 | 8.29 | 8.39 | 7.97 | 8.13 | 370565.0 |
| Oct 18, 2024 | 8.23 | 8.76 | 8.17 | 8.35 | 489766.0 |
| Oct 17, 2024 | 8.62 | 8.71 | 8.20 | 8.21 | 521148.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.09
Minimum
May 09 2022
41.77
Maximum
Mar 02 2020
15.76
Average
15.11
Median
Apr 13 2023
Price Benchmarks
| Madrigal Pharmaceuticals Inc | 320.90 |
| Eli Lilly and Co | 740.85 |
| Viking Therapeutics Inc | 52.25 |
| Akero Therapeutics Inc | 30.74 |
| NovaBay Pharmaceuticals Inc | 0.7026 |
Price Related Metrics
| Price to Book Value | 2.488 |
| Earnings Yield | -36.38% |
| Market Cap | 940.66M |